| Literature DB >> 23847548 |
Dimiter V Dimitrov1, Julia Hoeng.
Abstract
Current microbiome research has generated tremendous amounts of data providing snapshots of molecular activity in a variety of organisms, environments, and cell types. However, turning this knowledge into whole system level of understanding on pathways and processes has proven to be a challenging task. In this review we highlight the applicability of bioinformatics and visualization techniques to large collections of data in order to better understand the information that contains related diet-oral microbiome-host mucosal transcriptome interactions. In particular, we focus on systems biology of Porphyromonas gingivalis in the context of high throughput computational methods tightly integrated with translational systems medicine. Those approaches have applications for both basic research, where we can direct specific laboratory experiments in model organisms and cell cultures, and human disease, where we can validate new mechanisms and biomarkers for prevention and treatment of chronic disorders.Entities:
Keywords: Porphyromonas gingivalis; biomarkers; in silico modeling; oral microbiome; probiotics; systems biology; systems medicine; vaccines
Year: 2013 PMID: 23847548 PMCID: PMC3706740 DOI: 10.3389/fphys.2013.00172
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Translational systems biology approach for modeling of the oral microbiome. The proposed framework of different modules need be treated differently, i.e., stored differently, queried differently, and shown differently. For large data sets, it has proven efficient to follow Keim's Visual Analytics mantra: “Analyse First, Show the Important, Zoom, Filter and Analyse Further, Details on Demand” (Keim et al., 2006).
Figure 2Translational systems medicine: salivomics and vaccinomics of the oral microbiome. (A) The “Fatty Neck”—new emerging marker of inflammatory complications; (B) Salivary diagnostics (salivomics)—non-invasive and applicable approach for disease detection and follow up. (C) Personalized vaccinomics—for prediction of protein–ligand binding regions, vaccine design using computational vaccinology of responders vs. non-responders with the overall role for disease prevention.